Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
NPIL Pharma will expand its high-potency substances facility in Grangemouth, Scotland. The Indian firm, which bought the facility from Avecia in December 2005, says it will invest $500,000 and add 16 biochemists and other staffers in response to strong customer demand for cytotoxic pharmaceutical actives, in particular ones that are conjugated with monoclonal antibodies. NPIL says more than 20 of these immunoconjugates are in drug trials around the world.
This article has been sent to the following recipient: